One case of guggul possibly causing rhabdomyolysis after two weeks of therapy has been reported.[14] Other than this report, there is little evidence of severe adverse effects. Most adverse effects consist of rash, abdominal pain, diarrhea, nausea, headache, restlessness, and hiccups.[1,2]
American Journal of Health-System Pharmacy. 2005;62(10):1012-1014. © 2005 American Society of Health-System Pharmacists
processing....
Fast Five Quiz: Lipids Management: High HDL Cholesterol Levels (Hyperalphalipoproteinemia)
AACE Issues 'Cookbook' Algorithm to Manage Dyslipidemia
What Is the Role of SGLT2 Inhibitors in Patients With HFrEF?
Nonstatin Therapies and LDL-C Lowering: A Critical Analysis of the Data and Real-World Experiences
0.5 CME Credits
Large Study Links Brown Fat With Lower Rates of Cardiometabolic Disease
Comments